Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy-Reference-Cited by-同舟云学术

Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy

Published:2021-06-23 Issue:13 Volume:64 Page:8827-8869
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Adhikari Nilanjan¹^ORCID,Jha Tarun¹^ORCID,Ghosh Balaram²^ORCID

Affiliation:

1. Natural Science Laboratory, Division of Medicinal and Pharmaceutical Chemistry, Department of Pharmaceutical Technology, Jadavpur University, P.O. Box 17020, Kolkata, 700032 West Bengal, India

2. Epigenetic Research Laboratory, Department of Pharmacy, BITS-Pilani, Hyderabad Campus, Shamirpet, Hyderabad 500078, India

Funder

Council of Scientific and Industrial Research

University Grants Commission

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c01676

Reference308 articles.

1. Selective and nonselective HDAC8 inhibitors: a therapeutic patent review

2. Epigenetics in cancer: Fundamentals and Beyond

3. Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides

4. Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sucralose and stevia consumption leads to intergenerational alterations in body weight and intestinal expression of histone deacetylase 3;Nutrition;2024-09

2. A patent review of histone deacetylase 8 (HDAC8) inhibitors (2013–present);Expert Opinion on Therapeutic Patents;2024-08-20

3. Exploration of Hydrazide-Based HDAC8 PROTACs for the Treatment of Hematological Malignancies and Solid Tumors;Journal of Medicinal Chemistry;2024-08-01

4. Exploring different classification-dependent QSAR modelling strategies for HDAC3 inhibitors in search of meaningful structural contributors;SAR and QSAR in Environmental Research;2024-05-03

5. Targeting histone deacetylases in head and neck squamous cell carcinoma: molecular mechanisms and therapeutic targets;Journal of Translational Medicine;2024-05-03